Racura Oncology LtdASX: RAC

Racura Oncology Adelaide Investor Briefing

Sep 3, 2026 at 7:57 PM EDT · Issued by Racura Oncology Ltd via ASX

Filed with ASX · Sep 3, 2026 at 7:57 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/racura-oncology-adelaide-investor-briefing

Release

Racura Oncology Ltd | ABN 61 149 318 749 | L36 1 Macquarie Place Sydney NSW 2000 Australia +61 2 8051 3043 | [email protected] | www.racuraoncology.com 1 ASX Announcement Racura Oncology Adelaide Investor Brie fi ng 4 September 2026 Racura Oncology Ltd (“Racura” or the...

Racura Oncology Ltd on 6ix

Earlier from Racura Oncology

Notification regarding unquoted securities - RACAug 31
CPACS Trial Opens for RC220 Patient Enrolment in KoreaAug 31
Corporate Governance StatementAug 25
Appendix 4GAug 25
Appendix 4E & Annual ReportAug 25

Later from Racura Oncology

RC220 MYC-silencing data to be presented FCS 26 conferenceSep 7
Appendix 3Y - Dr Daniel TillettSep 22
Date of AGM & Closing Date for Director NominationsOct 4
Racura Presents CPACS Data at GCOS 2026Oct 6
HARNESS-1 First Cohort ClearedOct 11

All Racura Oncology news releases

Follow Racura Oncology into a list and get an email when it puts out news.

Follow Racura Oncology